Clinical Trial Update: Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating valproic acid with dihydroergotamine as abortive therapy in children with migraine was terminated; results were later posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Migraine in Children

Drugs mentioned

• Dihydroergotamine (dihydroergotamine)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Kimberly S Jones | Conditions: Migraine in Children | Phase 2 | Status: TERMINATED | Results posted: 2021-10-07